Navigation Links
Healthy Brains Depend Upon Survival Genes

A healthy brain can be maintained by a person at old age through activities that exercise the brain like a daily crossword puzzle. The University of Edinburgh’s scientists are doing further research on this subject// with the object of identifying the ‘survival genes’ in the brain.

The awakened genes add capacity to the brain to resist the after effects of drugs, strokes, and also contribute towards the development of the brain where unborn babies are concerned. Gene therapies and smarter drugs can be developed as a result of these findings, which will also contribute towards checking neurological diseases like Parkinson's and Alzheimer's disease. There is a reactivation process in the case of several unused genes when the brain cells are given stimulation, and these genes contribute towards an active brain.

The new discovery also has its implications upon unborn babies where the survival genes are affected by maternal drug taking. The turning on of the master genetic controller CREB results in the survival genes getting turned on. The research also targets at identifying the CREB-controlled genes which contribute towards the longer life of the brain, and make it more trauma resistant. The project is being funded by the Royal Society and Tenovus, and the Wellcome Trust.
'"/>




Page: 1

Related medicine news :

1. Want a Healthy brew? Have some Tea!
2. Healthy Medicine Or Harmful Intoxicant?
3. Healthy snacks improve nutrition of kids
4. Healthy ways to eat nourishing food
5. Helping Kids Attain a Healthy Weight
6. Counting Calories Might Be The Ideal Way To Stay Healthy
7. The Positive Effects Of A Healthy Lifestyle
8. The Positive Effects Of A Healthy Lifestyle
9. Reducing Disabilities By Following A Healthy Diet
10. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
11. Cobblestone Walking May Be The Key For Healthy Living.
Post Your Comments:
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...
(Date:12/5/2009)... Solutions, an innovative new international private medical insurance plan which follows ... offering customers the flexibility to add or remove a wide range ... customers to tailor their benefits to complement those already offered in ... ...
(Date:12/4/2009)... Inc. (NYSE: CRE ) ("Care" or the "Company") ... of $0.17 per share of common stock. The dividend is ... December 14, 2009. ,, About Care Investment ... investment and finance company investing in healthcare-related real estate and commercial ...
(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...
(Date:12/4/2009)... Calif., Dec. 4 Pamela Bowen, Chief Information Officer ... the "Chief Innovation Officer" Appy Award for transforming Crescent,s ... recipients are nominated based on their innovative usage of ... levels of customer success to their sales, marketing, partner, ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... as cholera would take the heaviest toll on survivors ... camps has intensified// the spread of pneumonia, and health ... in the already devastated region. ,In the ... groups such as the World Health Organization issued statements ...
... A recent study shows , schizophrenics treated with ... risk for developing type 2 diabetes. Patients taking ... impairment of glucose effectiveness compared with patients taking ... non-obese people with schizophrenia or schizoaffective disorder who ...
... world is infected with tuberculosis every second and someone dies ... have discovered easier tests to detect this deadly disease in ... generally done with a gastric lavage. It's an invasive test ... a sputum sample. Sputum is what comes up when you ...
... for urinary tract infections also put them at risk for ... ,Researchers interviewed 242 women who were treated for kidney ... automated databases. They then compared data from these cases to ... history of kidney infections. ,Results of the study showed ...
... after a mastectomy does not reduce the long-term survival of ... had a better chance of survival than those who did ... may boost the morale and self-esteem of the patient, which ... implants could stimulate the immune system and reduce blood flow ...
... can help maintain cognitive skills in people as they ... For the study researchers reviewed data on 295 men ... and Netherlands Elderly (FINE) study. The length and intensity ... cognitive function was evaluated starting in 1990. ,Results ...
Other Medicine News:
(Date:12/4/2009)... Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, announced today the presentation of new ... its lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine ... various temperatures up to and including 55 degrees C. ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 1Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 2Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 1Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 2Aethlon Medical Inc Announces Annual Meeting Results 14111 1Aethlon Medical Inc Announces Annual Meeting Results 14111 2Aethlon Medical Inc Announces Annual Meeting Results 14111 3
... Achieved at Least 75 Percent Improvement in Psoriasis,Signs ... Five Dosing Groups, More,Than Half Achieved 90 Percent ... -- New,Phase II study results show Abbott's investigational ... patients treated. At 12 weeks, nine out of ...
... Studies Suggest FTY720 Mechanisms in Multiple,Sclerosis May Include ... studies suggest FTY720 stimulates cells,that may help reduce ... multiple sclerosis , · Separately, analyses from the ... the proportion of,patients with clinical depression was significantly ...
Other Medicine Technology:Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9
... the Integrated Cytometry Solution offers a ... coupled with complete LIS connectivity. By ... sample undergoes - and managing the ... it delivers a progressive automated system ...
Convective Air Warming Blankets...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
Inquire...
Medicine Products: